Evaluation of DNA flow cytometry as a screening test for bladder cancer

A. D. Deitch, K. A. Anderson, Ralph W deVere White

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We evaluated DNA flow cytometry of urine histogram profiles as a screening method for bladder cancer. To establish the false-positive rate, we first studied a low-risk group of 90 patients with no history of bladder cancer: 24 with benign prostatic hyperplasia and 66 with upper tract stones, and found 4.4% unsatisfactory and 15.1% abnormal histograms. Urine samples were then obtained for 54 additional patients (most being evaluated for benign prostatic hyperplasia) whose selection was based on their smoking habits. These included 20 nonsmokers, 10 who had not smoked for at least 20 years (mean: 18 packs/year) and 24 current smokers (mean: 71 packs/year). Abnormal histograms were obtained for 14% of nonsmokers and for 36% of smokers, a group known to be at risk for developing bladder cancer. Although abnormal histograms are more freqent for smokers, the background false-positive rate remains unacceptably high for general screening purposes.

Original languageEnglish (US)
Pages (from-to)898-903
Number of pages6
JournalJournal of Occupational Medicine
Volume32
Issue number9
StatePublished - 1990

Fingerprint

Urinary Bladder Neoplasms
Flow Cytometry
Prostatic Hyperplasia
DNA
Urine
Habits
Smoking

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Evaluation of DNA flow cytometry as a screening test for bladder cancer. / Deitch, A. D.; Anderson, K. A.; deVere White, Ralph W.

In: Journal of Occupational Medicine, Vol. 32, No. 9, 1990, p. 898-903.

Research output: Contribution to journalArticle

@article{e24fa6c697f542d38bbbb87a5b384573,
title = "Evaluation of DNA flow cytometry as a screening test for bladder cancer",
abstract = "We evaluated DNA flow cytometry of urine histogram profiles as a screening method for bladder cancer. To establish the false-positive rate, we first studied a low-risk group of 90 patients with no history of bladder cancer: 24 with benign prostatic hyperplasia and 66 with upper tract stones, and found 4.4{\%} unsatisfactory and 15.1{\%} abnormal histograms. Urine samples were then obtained for 54 additional patients (most being evaluated for benign prostatic hyperplasia) whose selection was based on their smoking habits. These included 20 nonsmokers, 10 who had not smoked for at least 20 years (mean: 18 packs/year) and 24 current smokers (mean: 71 packs/year). Abnormal histograms were obtained for 14{\%} of nonsmokers and for 36{\%} of smokers, a group known to be at risk for developing bladder cancer. Although abnormal histograms are more freqent for smokers, the background false-positive rate remains unacceptably high for general screening purposes.",
author = "Deitch, {A. D.} and Anderson, {K. A.} and {deVere White}, {Ralph W}",
year = "1990",
language = "English (US)",
volume = "32",
pages = "898--903",
journal = "Journal of Occupational and Environmental Medicine",
issn = "1076-2752",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Evaluation of DNA flow cytometry as a screening test for bladder cancer

AU - Deitch, A. D.

AU - Anderson, K. A.

AU - deVere White, Ralph W

PY - 1990

Y1 - 1990

N2 - We evaluated DNA flow cytometry of urine histogram profiles as a screening method for bladder cancer. To establish the false-positive rate, we first studied a low-risk group of 90 patients with no history of bladder cancer: 24 with benign prostatic hyperplasia and 66 with upper tract stones, and found 4.4% unsatisfactory and 15.1% abnormal histograms. Urine samples were then obtained for 54 additional patients (most being evaluated for benign prostatic hyperplasia) whose selection was based on their smoking habits. These included 20 nonsmokers, 10 who had not smoked for at least 20 years (mean: 18 packs/year) and 24 current smokers (mean: 71 packs/year). Abnormal histograms were obtained for 14% of nonsmokers and for 36% of smokers, a group known to be at risk for developing bladder cancer. Although abnormal histograms are more freqent for smokers, the background false-positive rate remains unacceptably high for general screening purposes.

AB - We evaluated DNA flow cytometry of urine histogram profiles as a screening method for bladder cancer. To establish the false-positive rate, we first studied a low-risk group of 90 patients with no history of bladder cancer: 24 with benign prostatic hyperplasia and 66 with upper tract stones, and found 4.4% unsatisfactory and 15.1% abnormal histograms. Urine samples were then obtained for 54 additional patients (most being evaluated for benign prostatic hyperplasia) whose selection was based on their smoking habits. These included 20 nonsmokers, 10 who had not smoked for at least 20 years (mean: 18 packs/year) and 24 current smokers (mean: 71 packs/year). Abnormal histograms were obtained for 14% of nonsmokers and for 36% of smokers, a group known to be at risk for developing bladder cancer. Although abnormal histograms are more freqent for smokers, the background false-positive rate remains unacceptably high for general screening purposes.

UR - http://www.scopus.com/inward/record.url?scp=0025025603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025025603&partnerID=8YFLogxK

M3 - Article

C2 - 2074516

AN - SCOPUS:0025025603

VL - 32

SP - 898

EP - 903

JO - Journal of Occupational and Environmental Medicine

JF - Journal of Occupational and Environmental Medicine

SN - 1076-2752

IS - 9

ER -